|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019164,
umls-concept:C0019166,
umls-concept:C0019169,
umls-concept:C0025663,
umls-concept:C0035647,
umls-concept:C0868928,
umls-concept:C1527075,
umls-concept:C1527178,
umls-concept:C1551358,
umls-concept:C1609982,
umls-concept:C1705938,
umls-concept:C1879316
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-12-4
|
|
pubmed:abstractText |
To take into account the transient nature of hepatitis B virus (HBV) antigenemia, the calculation of HBV residual risk (RR), based on the incidence/window period model, is adjusted by a correction factor that adds uncertainty to the RR estimates.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1537-2995
|
|
pubmed:author |
pubmed-author:BarletValérieV,
pubmed-author:El GhouzziMarie-HélèneMH,
pubmed-author:LapercheSyriaS,
pubmed-author:Le VaconFrançoiseF,
pubmed-author:LevayerThierryT,
pubmed-author:LunelFrançoiseF,
pubmed-author:ManiezMichèleM,
pubmed-author:MorelPascalP,
pubmed-author:MouillotLaurenceL,
pubmed-author:PillonelJosianeJ,
pubmed-author:PiquetYvesY,
pubmed-author:Transfusion-Transmissible Agents Working Group, French National Society...
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2308-14
|
|
pubmed:dateRevised |
2009-5-11
|
|
pubmed:meshHeading |
pubmed-meshheading:18673347-Adult,
pubmed-meshheading:18673347-Algorithms,
pubmed-meshheading:18673347-Blood Donors,
pubmed-meshheading:18673347-Blood Transfusion,
pubmed-meshheading:18673347-DNA, Viral,
pubmed-meshheading:18673347-Female,
pubmed-meshheading:18673347-Follow-Up Studies,
pubmed-meshheading:18673347-France,
pubmed-meshheading:18673347-Hepatitis B,
pubmed-meshheading:18673347-Hepatitis B Antibodies,
pubmed-meshheading:18673347-Hepatitis B Core Antigens,
pubmed-meshheading:18673347-Hepatitis B Surface Antigens,
pubmed-meshheading:18673347-Hepatitis B e Antigens,
pubmed-meshheading:18673347-Humans,
pubmed-meshheading:18673347-Immunoglobulin M,
pubmed-meshheading:18673347-Incidence,
pubmed-meshheading:18673347-Male,
pubmed-meshheading:18673347-Models, Biological,
pubmed-meshheading:18673347-Retrospective Studies,
pubmed-meshheading:18673347-Risk,
pubmed-meshheading:18673347-Viremia
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
|
|
pubmed:affiliation |
Centre National de Référence pour les hépatites B et C en transfusion, Département des Agents Transmissibles par le Sang, Institut National de la Transfusion Sanguine, Paris, France. slaperche@ints.fr
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Validation Studies
|
